Phase 1/2 × Completed × Immunoglobulin Light-chain Amyloidosis × Clear all Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
Phase 1/2 Completed
18 enrolled
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Phase 1/2 Completed
28 enrolled
124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis
Phase 1/2 Completed
57 enrolled
Daratumumab for the Treatment of Patients With AL Amyloidosis
Phase 1/2 Completed
22 enrolled 10 charts
Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)
Phase 1/2 Completed
37 enrolled
CATALYST
Phase 1/2 Completed
10 enrolled 14 charts
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
Phase 1/2 Completed
27 enrolled 14 charts
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
Phase 1/2 Completed
21 enrolled
Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
Phase 1/2 Completed
69 enrolled
Bu Flu TBI
Phase 1/2 Completed
147 enrolled 19 charts
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
Phase 1/2 Completed
10 enrolled 4 charts
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Phase 1/2 Completed
30 enrolled
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
Phase 1/2 Completed
47 enrolled
Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis
Phase 1/2 Completed
27 enrolled
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Phase 1/2 Completed